autonomic and neurocardiovascular consulting limited Company Information
Company Number
07054371
Next Accounts
Nov 2024
Industry
Specialist medical practice activities
Shareholders
rosalind margaret mathias
christopher joseph mathias
Group Structure
View All
Contact
Registered Address
5 barnfield crescent, exeter, devon, EX1 1QT
Website
-autonomic and neurocardiovascular consulting limited Estimated Valuation
Pomanda estimates the enterprise value of AUTONOMIC AND NEUROCARDIOVASCULAR CONSULTING LIMITED at £1.4m based on a Turnover of £2.6m and 0.54x industry multiple (adjusted for size and gross margin).
autonomic and neurocardiovascular consulting limited Estimated Valuation
Pomanda estimates the enterprise value of AUTONOMIC AND NEUROCARDIOVASCULAR CONSULTING LIMITED at £357.7k based on an EBITDA of £88.2k and a 4.05x industry multiple (adjusted for size and gross margin).
autonomic and neurocardiovascular consulting limited Estimated Valuation
Pomanda estimates the enterprise value of AUTONOMIC AND NEUROCARDIOVASCULAR CONSULTING LIMITED at £3.4m based on Net Assets of £1.3m and 2.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Autonomic And Neurocardiovascular Consulting Limited Overview
Autonomic And Neurocardiovascular Consulting Limited is a dissolved company that was located in devon, EX1 1QT with a Companies House number of 07054371. It operated in the specialists medical practice activities sector, SIC Code 86220. Founded in October 2009, it's largest shareholder was rosalind margaret mathias with a 66.7% stake. The last turnover for Autonomic And Neurocardiovascular Consulting Limited was estimated at £2.6m.
Upgrade for unlimited company reports & a free credit check
Autonomic And Neurocardiovascular Consulting Limited Health Check
Pomanda's financial health check has awarded Autonomic And Neurocardiovascular Consulting Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £2.6m, make it larger than the average company (£246.4k)
- Autonomic And Neurocardiovascular Consulting Limited
£246.4k - Industry AVG
Growth
3 year (CAGR) sales growth of 29%, show it is growing at a faster rate (5.5%)
- Autonomic And Neurocardiovascular Consulting Limited
5.5% - Industry AVG
Production
with a gross margin of 42.3%, this company has a higher cost of product (69.3%)
- Autonomic And Neurocardiovascular Consulting Limited
69.3% - Industry AVG
Profitability
an operating margin of 3.4% make it less profitable than the average company (29.8%)
- Autonomic And Neurocardiovascular Consulting Limited
29.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (13)
2 - Autonomic And Neurocardiovascular Consulting Limited
13 - Industry AVG
Pay Structure
on an average salary of £24.6k, the company has an equivalent pay structure (£24.6k)
- Autonomic And Neurocardiovascular Consulting Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £1.3m, this is more efficient (£57.9k)
- Autonomic And Neurocardiovascular Consulting Limited
£57.9k - Industry AVG
Debtor Days
it gets paid by customers after 192 days, this is later than average (39 days)
- Autonomic And Neurocardiovascular Consulting Limited
39 days - Industry AVG
Creditor Days
its suppliers are paid after 7 days, this is quicker than average (31 days)
- Autonomic And Neurocardiovascular Consulting Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Autonomic And Neurocardiovascular Consulting Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Autonomic And Neurocardiovascular Consulting Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.2%, this is a lower level of debt than the average (33.9%)
2.2% - Autonomic And Neurocardiovascular Consulting Limited
33.9% - Industry AVG
AUTONOMIC AND NEUROCARDIOVASCULAR CONSULTING LIMITED financials
Autonomic And Neurocardiovascular Consulting Limited's latest turnover from March 2018 is estimated at £2.6 million and the company has net assets of £1.3 million. According to their latest financial statements, Autonomic And Neurocardiovascular Consulting Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | ||||||||
Number Of Employees | 2 | 2 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 3,750 | 5,400 | 5,851 | 5,807 | 7,143 | 4,204 | 2,413 | 3,290 |
Intangible Assets | 0 | 0 | 0 | 5,000 | 113,332 | 169,999 | 226,666 | 283,333 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 3,750 | 5,400 | 5,851 | 10,807 | 120,475 | 174,203 | 229,079 | 286,623 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 1,359,267 | 1,389,049 | 309,022 | 223,548 | 4,594 | 5,410 | 2,983 | 9,067 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 4,329 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 801,200 | 724,444 | 817,633 | 603,809 | 324,224 | 280,582 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,359,267 | 1,393,378 | 1,110,222 | 947,992 | 822,227 | 609,219 | 327,207 | 289,649 |
total assets | 1,363,017 | 1,398,778 | 1,116,073 | 958,799 | 942,702 | 783,422 | 556,286 | 576,272 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 30,513 | 137,749 | 70,524 | 60,200 | 368,773 | 240,066 | 215,429 | 364,616 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 30,513 | 137,749 | 70,524 | 60,200 | 368,773 | 240,066 | 215,429 | 364,616 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 30,513 | 137,749 | 70,524 | 60,200 | 368,773 | 240,066 | 215,429 | 364,616 |
net assets | 1,332,504 | 1,261,029 | 1,045,549 | 898,599 | 573,929 | 543,356 | 340,857 | 211,656 |
total shareholders funds | 1,332,504 | 1,261,029 | 1,045,549 | 898,599 | 573,929 | 543,356 | 340,857 | 211,656 |
Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 4,069 | 4,070 | 2,661 | 1,767 | 877 | 1,097 | ||
Amortisation | 5,000 | 56,667 | 56,667 | 56,667 | 56,667 | 56,667 | ||
Tax | ||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -34,111 | 1,084,356 | 85,474 | 218,954 | -816 | 2,427 | -6,084 | 9,067 |
Creditors | -107,236 | 67,225 | 10,324 | -308,573 | 128,707 | 24,637 | -149,187 | 364,616 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | 0 | -801,200 | 76,756 | -93,189 | 213,824 | 279,585 | 43,642 | 280,582 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | -801,200 | 76,756 | -93,189 | 213,824 | 279,585 | 43,642 | 280,582 |
autonomic and neurocardiovascular consulting limited Credit Report and Business Information
Autonomic And Neurocardiovascular Consulting Limited Competitor Analysis
Perform a competitor analysis for autonomic and neurocardiovascular consulting limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in EX1 area or any other competitors across 12 key performance metrics.
autonomic and neurocardiovascular consulting limited Ownership
AUTONOMIC AND NEUROCARDIOVASCULAR CONSULTING LIMITED group structure
Autonomic And Neurocardiovascular Consulting Limited has no subsidiary companies.
Ultimate parent company
AUTONOMIC AND NEUROCARDIOVASCULAR CONSULTING LIMITED
07054371
autonomic and neurocardiovascular consulting limited directors
Autonomic And Neurocardiovascular Consulting Limited currently has 2 directors. The longest serving directors include Prof Christopher Mathias (Oct 2009) and Mrs Rosalind Mathias (Oct 2009).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Prof Christopher Mathias | 75 years | Oct 2009 | - | Director | |
Mrs Rosalind Mathias | 76 years | Oct 2009 | - | Director |
P&L
March 2018turnover
2.6m
-17%
operating profit
88.2k
0%
gross margin
42.3%
-6.14%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2018net assets
1.3m
+0.06%
total assets
1.4m
-0.03%
cash
0
0%
net assets
Total assets minus all liabilities
autonomic and neurocardiovascular consulting limited company details
company number
07054371
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
October 2009
age
15
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2018
previous names
N/A
accountant
-
auditor
-
address
5 barnfield crescent, exeter, devon, EX1 1QT
Bank
-
Legal Advisor
-
autonomic and neurocardiovascular consulting limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to autonomic and neurocardiovascular consulting limited.
autonomic and neurocardiovascular consulting limited Companies House Filings - See Documents
date | description | view/download |
---|